Page 58 - AN-3-2
P. 58

Advanced Neurology                                               Inflammation in diabetic stroke: Pathogenesis



               Pathophysiology. 2010;17(3):197-218.               by increasing LDL transcytosis across endothelial cells
                                                                  via  RAGE/NF-kappaB/Caveolin-1  pathway.  Mol Med.
               doi: 10.1016/j.pathophys.2009.12.001
                                                                  2023;29(1):113.
            8.   Iadecola C, Buckwalter MS, Anrather J. Immune responses
               to stroke: Mechanisms, modulation, and therapeutic      doi: 10.1186/s10020-023-00715-5
               potential. J Clin Invest. 2020;130(6):2777-2788.  20.  Yu W, Tao M, Zhao Y, Hu X, Wang M. 4’-methoxyresveratrol
                                                                  alleviated AGE-induced inflammation via RAGE-mediated
               doi: 10.1172/JCI135530
                                                                  NF-kappaB and NLRP3 inflammasome pathway. Molecules.
            9.   Mulnier HE, Seaman HE, Raleigh VS, et al. Risk of stroke   2018;23(6):1447.
               in people with type  2 diabetes in the UK: A  study using      doi: 10.3390/molecules23061447
               the general practice research database.  Diabetologia.
               2006;49(12):2859-2865.                          21.  Chawla  D,  Bansal  S,  Banerjee  BD,  Madhu  SV,  Kalra  OP,
                                                                  Tripathi AK. Role of advanced glycation end product
               doi: 10.1007/s00125-006-0493-z
                                                                  (AGE)-induced receptor (RAGE) expression in diabetic
            10.  Jebari-Benslaiman S, Galicia-Garcia U, Larrea-Sebal A,   vascular complications. Microvasc Res. 2014;95:1-6.
               et al. Pathophysiology of atherosclerosis.  Int J Mol Sci.
               2022;23(6):3346.                                   doi: 10.1016/j.mvr.2014.06.010
                                                               22.  Da Veiga GL, Della Nina Raffo MG, da Costa Aguiar Alves B,
               doi: 10.3390/ijms23063346
                                                                  Bacci MR, Fonseca FLA. NF-κB gene expression in
            11.  Libby P. The changing landscape of atherosclerosis. Nature.   peripheral blood and urine in early diagnosis of diabetic
               2021;592(7855):524-533.                            nephropathy - A liquid biopsy approach. Urine. 2019;1:24-28.
               doi: 10.1038/s41586-021-03392-8                    doi: 10.1016/j.urine.2020.05.005
            12.  Liu T, Zhang L, Joo D, Sun SC. NF-kappaB signaling in   23.  Gromotowicz-Poplawska A, Kloza M, Aleksiejczuk M, et al.
               inflammation. Signal Transduct Target Ther. 2017;2:17023.  Nitric oxide as a modulator in platelet- and endothelium-
                                                                  dependent antithrombotic effect of eplerenone in diabetic
               doi: 10.1038/sigtrans.2017.23
                                                                  rats. J Physiol Pharmacol. 2019;70(2).
            13.  Bentzon JF, Otsuka F, Virmani R, Falk E. Mechanisms of plaque
               formation and rupture. Circ Res. 2014;114(12):1852-1866.     doi: 10.26402/jpp.2019.2.02
                                                               24.  Jamwal S, Sharma S. Vascular endothelium dysfunction:
               doi: 10.1161/CIRCRESAHA.114.302721
                                                                  A conservative target in metabolic disorders. Inflamm Res.
            14.  Mao  R,  Zong  N,  Hu  Y,  Chen  Y,  Xu  Y.  Neuronal  death   2018;67(5):391-405.
               mechanisms and therapeutic strategy in ischemic stroke.      doi: 10.1007/s00011-018-1129-8
               Neurosci Bull. 2022;38(10):1229-1247.
                                                               25.  Tejero J, Shiva S, Gladwin MT. Sources of vascular nitric
               doi: 10.1007/s12264-022-00859-0
                                                                  oxide and reactive oxygen species and their regulation.
            15.  Sabitha Vadakedath VK. Role of advanced glycation end   Physiol Rev. 2019;99(1):311-379.
               products (AGE) in health and disease: An overview. Biochem
               Physiol. 2018;7:246.                               doi: 10.1152/physrev.00036.2017
                                                               26.  Stefano GB, Challenger S, Kream RM. Hyperglycemia-
               doi: 10.4172/2168-9652.1000246
                                                                  associated alterations in cellular signaling and dysregulated
            16.  Knott HM, Brown BE, Davies MJ, Dean RT. Glycation and   mitochondrial bioenergetics in human metabolic disorders.
               glycoxidation of low-density lipoproteins by glucose and low-  Eur J Nutr. 2016;55(8):2339-2345.
               molecular mass aldehydes. Formation of modified and oxidized
               particles. Eur J Biochem. 2003;270(17):3572-3582.     doi: 10.1007/s00394-016-1212-2
                                                               27.  Brownlee M. Biochemistry and molecular cell biology of
               doi: 10.1046/j.1432-1033.2003.03742.x
                                                                  diabetic complications. Nature. 2001;414(6865):813-820.
            17.  Kheniser KG, Kashyap SR, Kasumov T. A systematic review:      doi: 10.1038/414813a
               The  appraisal  of  the  effects  of  metformin  on  lipoprotein
               modification and function. Obes Sci Pract. 2019;5(1):36-45.  28.  Juge-Aubry CE, Henrichot E, Meier CA. Adipose tissue:
                                                                  A regulator of inflammation. Best Pract Res Clin Endocrinol
               doi: 10.1002/osp4.309
                                                                  Metab. 2005;19(4):547-566.
            18.  Indyk D, Bronowicka-Szydelko A, Gamian A, Kuzan A.      doi: 10.1016/j.beem.2005.07.009
               Advanced glycation end products and their receptors in serum
               of patients with type 2 diabetes. Sci Rep. 2021;11(1):13264.  29.  Bidulescu A, Dinh PC Jr., Sarwary S, et al. Associations of
                                                                  leptin and adiponectin with incident type  2 diabetes and
               doi: 10.1038/s41598-021-92630-0
                                                                  interactions among African Americans: The Jackson heart
            19.  Shu M, Cheng W, Jia X, et al. AGEs promote atherosclerosis   study. BMC Endocr Disord. 2020;20(1):31.


            Volume 3 Issue 2 (2024)                         8                                doi: 10.36922/an.1683
   53   54   55   56   57   58   59   60   61   62   63